HealthIT Answers shares Phreesia’s announcement on its contract renewal with CMMI for continued use of the Patient Activation Measure® (PAM).

Healthcare Innovation published an interview with Phreesia’s Chief Clinical Officer Hilary Hatch, PhD, who shared how Phreesia enhances healthcare for LGBTQ+ individuals by enabling the collection of sensitive information, such as SOGI data, to improve patient care and outcomes.

Healthcare IT Today shared insights from Phreesia’s Chief Clinical Officer Hilary Hatch, PhD, on how digital tools can help patients take a more active role in their care and ultimately improve population health outcomes.

Healthcare IT News featured insights from Phreesia’s Chief Clinical Officer Hilary Hatch, PhD, on how digital tools that allow patients to self-report SDOH data help improve patient engagement and reduce burden on providers.

Healthcare IT Today featured Phreesia’s announcement on achieving the Oracle Validated Integration with Oracle Health EHR Expertise. The outlet also shared that Phreesia renewed its contract with CMMI through 2029 to support the kidney care alternative payment model.

Healthcare Innovation features announcement on CMMI renewing its contract with Phreesia for use of the Patient Activation Measure (PAM) through 2029.

Medical Economics published an op-ed by Phreesia’s own Chief Clinical Officer Hilary Hatch, PhD, on how to improve medication adherence for patients while minimizing additional workload for providers.

Healthcare IT Today features Phreesia’s collaboration with the Ad Council to bring three public health campaigns about mental health directly to patients and caregivers.

Slice of Healthcare features announcement on CMMI renewing its contract with Phreesia for use of the Patient Activation Measure (PAM) through 2029.

Nephrology Times shares announcement on CMMI renewing its contract with Phreesia for use of the Patient Activation Measure (PAM) through 2029.